Medical and Pharmaceutical Bright Minds Bio soars on US$35M private placement; up 5,400% in 5 days Developing drugs for the treatment of epilepsy, depression, obesity and other conditions is the company's forte Rowan DunneOctober 18, 2024
Business Avicanna files patent for cannabinoid med that reduces epileptic seizures, sudden death A number of the medical cannabis maker's products are available to Canadian patients Natalia Buendia CalvilloSeptember 24, 2021
Industry update GW Pharma shares soar 21% on rising revenues The cannabinoid drugmaker also launched a Phase 3 trial for a multiple sclerosis treatment Jared GnamNovember 3, 2020
Medical and Pharmaceutical GW Pharma asks FDA to approve Epidiolex to treat a third epileptic disorder The cannabis-based medicine could treat seizures associated with Tuberous Sclerosis Complex Michelle GamageFebruary 3, 2020